Gary Lin, MD | UniHealth

Offices

1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: El Camino Health. That is not proof they admit you there this week.

Plans that list them

2 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lin’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

2 of 2 plans

Sort by

Plans whose provider directory lists this clinician

SCAN Strive (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
DualConnect (HMO D-SNP)	Santa Clara Family Health Plan	Listed	Sep 1, 2026

California Medical Board record

Licence A138730 · Current

Licensed to practise in California · since 2015 · expires 2027-10-31 · University of California, San Diego School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend it
Overall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025

See every measure and the patient survey for El Camino Health

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at El Camino Health

Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.291	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.393	Better	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0	Better	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	0.96 (0.12 to 1.79) · 2,340 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	1.02 (0.76 to 1.28)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	167.38 (125.03 to 209.73) · 96 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	2.6 · 68 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	7.1 · 185 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	11.8 · 200 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	8.9 · 814 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	13 · 842 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	9.6 · 361 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.6 · 4,633 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.16 (0 to 0.34) · 11,474 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.27 (0.1 to 0.45) · 11,626 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	3.14 (1.39 to 4.9) · 2,814 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	2 (0.61 to 3.39) · 1,327 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.11 (0.8 to 3.43) · 2,641 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	9.39 (4.18 to 14.6) · 1,287 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	6.57 (3.47 to 9.68) · 1,308 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	2.14 (0.71 to 3.57) · 827 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.6 (0.05 to 1.15) · 9,460 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	4.5 · 122 cases	None	Apr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.993	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.706	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	1.376	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	15.5 · 218 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	19.5 · 962 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	3.8 · 200 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-17 · 922 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	18.6 · 860 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	18.7 · 827 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	6.1 (4.5 to 8.2) · 313 cases	No different	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	13.4 (10.6 to 16.5) · 313 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	6.1 · 144 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	10.3 · 80 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20.7 · 237 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.8 (10 to 16.1) · 1,639 cases	No different	Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.9 (0.8 to 1.1) · 1,619 cases	No different	Jan 2024 – Dec 2024

What patients said (1,535 patients answered, 22% of those asked)

Sort by

Patient survey stars by topic at El Camino Health

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	3
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at El Camino Health

Room was "always" clean	75%
Nurses "always" communicated well	79%
Doctors "always" communicated well	81%
Staff "always" explained	61%
Yes, staff "did" give patients this information	86%
Yes, staff "did" give patients information about help after discharge	86%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	76%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	75%
Nurses "always" listened carefully	76%
Nurses "always" treated them with courtesy and respect	87%
"Always" quiet at night	47%
"YES", patients would definitely recommend the hospital	80%
Staff "always" explained possible side effects	46%
Yes, staff "did" give patients information about possible symptoms	86%

Original Medicare doctor bills

$136,463

Medicare paid this office $136,463 for 475 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Critical care, first 30-74 minutes	86	$46,876	$183
Short return visit (20+ min)	240	$30,805	$78
New patient visit (60+ min)	110	$21,073	$192
Test to examine how well the lungs exchange gases	107	$6,473	$58
Test to determine lung volumes using sensors	106	$6,259	$57

See all 13 services

Sort by

Every Original Medicare service billed

Critical care, first 30-74 minutes	86	$46,876	$183
Short return visit (20+ min)	240	$30,805	$78
New patient visit (60+ min)	110	$21,073	$192
Test to examine how well the lungs exchange gases	107	$6,473	$58
Test to determine lung volumes using sensors	106	$6,259	$57
Return visit (30+ min)	31	$4,382	$112
Long return visit (40+ min)	25	$4,253	$170
Test to measure expiratory airflow and volume changes before and after medication administration	84	$3,360	$40
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	168	$3,078	$15
Critical care, each additional 30 minutes	23	$2,137	$93
Influenza vaccine split virus, preservative free	11	$972	$81
Test to measure expiratory airflow and volume	30	$863	$27
Administration of influenza virus vaccine	11	$469	$39

Who their Medicare patients are

475 Original Medicare patients in 2024. Average age 78 · Under 65 3% · 85 and older 25% · Women 54% · Also on Medicaid 18% · Health risk score 1.66. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 2.58.

Conditions among them: High blood pressure 75% · COPD 35% · Chronic kidney disease 33% · Diabetes 31% · Coronary heart disease 31% · Atrial fibrillation 30% · Heart failure 27% · Depression 22% · Cancer 19% · Stroke 13% · Dementia 10%.

The office billed $611,235, Medicare allowed $181,883 and paid $136,463; for 1,483 services of 31 kinds; $1,469 of it was for drugs given in the office and $134,994 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	475	1,483	78	1.66	$611,235	$136,463
2023	449	1,588	78	1.61	$534,753	$133,824
2022	465	1,415	77	1.74	$558,291	$142,177
2021	356	1,364	78	1.49	$434,054	$121,729
2020	57	123	75	2.17	$72,047	$19,016

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 14 services

Sort by

Original Medicare services billed in 2023

Short return visit (20+ min)	241	$33,882	$81
Critical care, first 30-74 minutes	57	$29,347	$192
New patient visit (60+ min)	111	$22,126	$199
Long return visit (40+ min)	49	$8,339	$160
Test to examine how well the lungs exchange gases	118	$7,161	$57
Test to determine lung volumes using sensors	117	$6,866	$55
Test to measure expiratory airflow and volume changes before and after medication administration	98	$3,685	$36
Return visit (30+ min)	24	$3,324	$119
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	16	$1,913	$120
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	11	$1,566	$75
Critical care, each additional 30 minutes	15	$1,447	$96
Influenza vaccine split virus, preservative free	15	$1,079	$72
Test to measure expiratory airflow and volume	27	$893	$28
Administration of influenza virus vaccine	16	$605	$38

2022: 15 services

Sort by

Original Medicare services billed in 2022

Critical care, first 30-74 minutes	82	$43,556	$199
Short return visit (20+ min)	191	$28,643	$82
New patient visit (60+ min)	94	$19,608	$209
Long return visit (40+ min)	70	$11,989	$167
Test to examine how well the lungs exchange gases	106	$6,118	$58
Test to determine lung volumes using sensors	106	$5,620	$53
Return visit (30+ min)	47	$4,526	$92
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes	22	$3,616	$65
Test to measure expiratory airflow and volume changes before and after medication administration	89	$3,260	$37
Critical care, each additional 30 minutes	30	$3,127	$101
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	18	$2,252	$125
New patient visit (45+ min)	13	$975	$75
Influenza vaccine split virus, preservative free	13	$878	$68
Administration of influenza virus vaccine	21	$796	$38
Test to measure expiratory airflow and volume	24	$627	$26

2021: 12 services

Sort by

Original Medicare services billed in 2021

Critical care, first 30-74 minutes	87	$37,506	$199
Return visit (30+ min)	112	$14,257	$125
New patient visit (45+ min)	89	$13,168	$148
Short return visit (20+ min)	88	$10,935	$86
Long return visit (40+ min)	33	$5,724	$173
Test to examine how well the lungs exchange gases	64	$4,143	$65
Test to determine lung volumes using sensors	64	$3,743	$58
Test to measure expiratory airflow and volume changes before and after medication administration	53	$2,601	$49
Critical care, each additional 30 minutes	24	$2,402	$100
Influenza vaccine split virus, preservative free	34	$2,219	$65
Administration of influenza virus vaccine	34	$735	$22
Test to measure expiratory airflow and volume	15	$470	$31

2020: 2 services

Sort by

Original Medicare services billed in 2020

Critical care, first 30-74 minutes	30	$13,244	$214
New patient visit (30+ min)	14	$1,439	$103

Drugs they prescribed that Part D paid

$1,845,850

Pharmacies billed $1,845,850 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,494) in 2024. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 0%.

495 generic and 999 brand-name prescriptions · $1,845,850 in drug cost · 66 antibiotic prescriptions to 40 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Ofev	87	$1,124,344	$12,923
Trelegy Ellipta	175	$170,882	$976
Zemaira	13	$137,753	$10,596
Anoro Ellipta	103	$71,745	$697
Breo Ellipta	138	$66,678	$483

See all 29 drugs

Sort by

Every Part D drug this clinician prescribed

Ofev	87	$1,124,344	$12,923
Trelegy Ellipta	175	$170,882	$976
Zemaira	13	$137,753	$10,596
Anoro Ellipta	103	$71,745	$697
Breo Ellipta	138	$66,678	$483
Dupixent	13	$46,108	$3,547
Stiolto Respimat	48	$27,173	$566
Spiriva Handihaler	26	$23,099	$888
Spiriva Respimat	24	$19,057	$794
Incruse Ellipta	34	$18,320	$539
Combivent Respimat	20	$15,510	$776
Mycophenolate Mofetil	39	$15,430	$396
Dulera	19	$11,789	$620
Breztri Aerosphere	14	$8,216	$587
Symbicort	18	$7,428	$413
Wixela Inhub	55	$6,188	$113
Albuterol Sulfate Hfa	191	$5,646	$30
Fluticasone-Salmeterol	32	$5,255	$164
Arnuity Ellipta	18	$4,991	$277
Azelastine	44	$1,911	$43
Ethambutol	17	$1,886	$111
Rifampin	18	$1,657	$92
Ventolin Hfa	26	$1,531	$59
Fluticasone Propionate	66	$969	$15
Levalbuterol Tartrate Hfa	15	$874	$58
Azithromycin	34	$726	$21
Ipratropium	13	$505	$39
Montelukast	21	$213	$10
Prednisone	51	$210	$4

Year by year

Sort by

Part D prescribing by year

2024	1,494	241	0% (0)	67%	$1,845,850
2023	1,207	234	0% (0)	69%	$1,325,995
2022	1,008	208	0% (0)	65%	$1,014,456
2021	401	135	0% (0)	56%	$291,356
2020	235	45	0% (0)	57%	$68,932
2019	185	40	0% (0)	44%	$40,011
2018	81	27	0% (0)	44%	$10,992

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 26 drugs

Sort by

Part D drugs prescribed in 2023

Ofev	50	$664,805	$13,296
Trelegy Ellipta	169	$173,391	$1,026
Zemaira	12	$125,006	$10,417
Anoro Ellipta	93	$64,379	$692
Breo Ellipta	78	$57,273	$734
Stiolto Respimat	51	$36,667	$719
Incruse Ellipta	41	$26,324	$642
Spiriva Handihaler	25	$26,224	$1,049
Symbicort	33	$22,149	$671
Spiriva Respimat	30	$20,632	$688
Advair Diskus	29	$15,786	$544
Combivent Respimat	17	$12,853	$756
Wixela Inhub	28	$10,768	$385
Advair Hfa	14	$6,425	$459
Albuterol Sulfate Hfa	140	$6,206	$44
Dulera	18	$6,098	$339
Mycophenolate Mofetil	19	$2,692	$142
Ethambutol	26	$2,604	$100
Rifampin	27	$2,113	$78
Azelastine	37	$1,685	$46
Ventolin Hfa	20	$1,546	$77
Levalbuterol Tartrate Hfa	19	$1,097	$58
Fluticasone Propionate	45	$782	$17
Azithromycin	35	$691	$20
Montelukast	21	$441	$21
Prednisone	33	$232	$7

2022: 23 drugs

Sort by

Part D drugs prescribed in 2022

Ofev	35	$437,954	$12,513
Trelegy Ellipta	133	$135,769	$1,021
Stiolto Respimat	45	$32,821	$729
Breo Ellipta	45	$32,402	$720
Anoro Ellipta	53	$32,061	$605
Spiriva Respimat	54	$31,106	$576
Symbicort	52	$28,553	$549
Incruse Ellipta	42	$25,925	$617
Spiriva Handihaler	24	$19,211	$800
Advair Diskus	36	$17,572	$488
Wixela Inhub	37	$10,100	$273
Arnuity Ellipta	24	$7,791	$325
Albuterol Sulfate Hfa	93	$3,893	$42
Rifampin	19	$2,143	$113
Ventolin Hfa	19	$1,533	$81
Ethambutol	15	$1,531	$102
Azelastine	30	$1,525	$51
Mycophenolate Mofetil	24	$1,495	$62
Fluticasone Propionate	57	$1,362	$24
Azithromycin	19	$964	$51
Levalbuterol Tartrate Hfa	12	$708	$59
Montelukast	18	$492	$27
Prednisone	25	$277	$11

2021: 13 drugs

Sort by

Part D drugs prescribed in 2021

Ofev	12	$146,244	$12,187
Stiolto Respimat	33	$18,929	$574
Spiriva Respimat	31	$16,623	$536
Trelegy Ellipta	18	$14,924	$829
Anoro Ellipta	21	$11,979	$570
Symbicort	27	$11,196	$415
Advair Diskus	11	$5,823	$529
Albuterol Sulfate Hfa	50	$2,354	$47
Ventolin Hfa	11	$1,056	$96
Mycophenolate Mofetil	12	$957	$80
Fluticasone Propionate	22	$532	$24
Montelukast	12	$286	$24
Prednisone	21	$201	$10

2020: 11 drugs

Sort by

Part D drugs prescribed in 2020

Spiriva Respimat	30	$17,282	$576
Stiolto Respimat	29	$15,248	$526
Advair Diskus	12	$6,143	$512
Spiriva	12	$5,986	$499
Ventolin Hfa	11	$816	$74
Ipratropium	14	$627	$45
Albuterol Sulfate Hfa	12	$495	$41
Montelukast	32	$438	$14
Azithromycin	11	$285	$26
Fluticasone Propionate	14	$215	$15
Prednisone	13	$139	$11

2019: 5 drugs

Sort by

Part D drugs prescribed in 2019

Spiriva Respimat	20	$9,676	$484
Advair Diskus	12	$5,809	$484
Azithromycin	18	$745	$41
Ipratropium	20	$580	$29
Montelukast	21	$363	$17

Money from drug and device companies

$163 in 2025

Sort by

Industry payments by year

2025	5	7	None	$163
2024	3	4	None	$115
2023	1	2	None	$43
2021	1	1	None	$14
2019	2	3	None	$311

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

GlaxoSmithKline	Nucala	$45	2 payments Meals for Nucala · 2025-07-11 · $26 Meals for Nucala · 2025-01-17 · $19
Insmed	Arikayce	$36	2 payments Meals for Arikayce · 2025-09-23 · $18 Education for Brinsupri · 2025-09-23 · $17
Boehringer Ingelheim Pharmaceuticals	Ofev	$32	1 payment Meals for Ofev · 2025-02-28 · $32
Philips North America	Vest Therapy Und	$28	1 payment Meals for Vest Therapy Und · 2025-04-23 · $28
Genentech USA	Xolair	$23	1 payment Meals for Xolair · 2025-09-05 · $23

See all 7 published payments

Sort by

Every published payment

Insmed	Meals · 2025-09-23	Arikayce	$18
Insmed	Education · 2025-09-23	Brinsupri	$17
Genentech USA	Meals · 2025-09-05	Xolair	$23
GlaxoSmithKline	Meals · 2025-07-11	Nucala	$26
Philips North America	Meals · 2025-04-23	Vest Therapy Und	$28
Boehringer Ingelheim Pharmaceuticals	Meals · 2025-02-28	Ofev	$32
GlaxoSmithKline	Meals · 2025-01-17	Nucala	$19

See earlier years (2024, 2023, 2021, 2019)

2024: $115

Sort by

Payments by company in 2024

Boehringer Ingelheim Pharmaceuticals	Ofev	$63	2 payments Meals for Ofev · 2024-06-21 · $30 Meals for Ofev · 2024-02-01 · $32
Amgen	Tezspire	$33	1 payment Meals for Tezspire · 2024-12-12 · $33
GlaxoSmithKline	Nucala	$20	1 payment Meals for Nucala · 2024-09-24 · $20

2023: $43

Sort by

Payments by company in 2023

Boehringer Ingelheim Pharmaceuticals	Ofev	$43	2 payments Meals for Ofev · 2023-08-02 · $22 Meals for Ofev · 2023-02-21 · $22

2021: $14

Sort by

Payments by company in 2021

GlaxoSmithKline	Anoro Ellipta	$14	1 payment Meals for Anoro Ellipta · 2021-03-15 · $14

2019: $311

Sort by

Payments by company in 2019

Boehringer Ingelheim Pharmaceuticals	None	$187	2 payments Meals · 2019-11-20 · $81 Meals · 2019-04-11 · $106
Allergan	Avycaz	$123	1 payment Meals for Avycaz · 2019-03-26 · $123

Professional record

NPI: 1811315534
Licence: CA A138730California A138730: Current · expires 2027-10-31
Trained: University of California, San Diego School of Medicine, 2014
Group: Sutter Bay Medical Foundation
Video visits: Lists video visits
Gender: Male

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207RP1001X (207RP1001X)
Mailing address: 325 Distel Cir, Los Altos, CA, 94022
NPI first listed: 2014-03-31
NPI last updated: 2020-09-28
NPI record certified: 2020-09-28

This is when the NPI record was last certified, not a medical board exam.